Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Matthias

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Thrombosis and Haemostasis|April 30, 1976
Studies on chemically modified fibrinogenM Kloczewiak, Z Wegrzynowicz, F R Matthias, et al.
Klinische Wochenschrift|June 1, 1977
[Dysfibrinogenemia. A new case: dysfibrinogenemia Giessen III (author's transl)]F R Matthias, W H Krause, S Ganssert, et al.
Zeitschrift Fur Kardiologie|January 24, 2004
[Persistent angina pectoris in spite of successful myocardial revascularisation]O Kohl, M Grebe, H Hölschermann, et al.
Medizinische Klinik (Munich, Germany : 1983)|November 15, 1996
[Coronary risk factors in chronic hemodialysis patients]F Lübbecke, F R Matthias, U Richter, et al.
Thrombosis Research|November 15, 1983
Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparinH Ditter, D Heinrich, F R Matthias, et al.
Intensive Care Medicine|August 29, 1998
Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsisB Eisele, M Lamy, L G Thijs, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Thrombosis and Haemostasis|April 30, 1976
Studies on chemically modified fibrinogenM Kloczewiak, Z Wegrzynowicz, F R Matthias, et al.
Klinische Wochenschrift|June 1, 1977
[Dysfibrinogenemia. A new case: dysfibrinogenemia Giessen III (author's transl)]F R Matthias, W H Krause, S Ganssert, et al.
Zeitschrift Fur Kardiologie|January 24, 2004
[Persistent angina pectoris in spite of successful myocardial revascularisation]O Kohl, M Grebe, H Hölschermann, et al.
Medizinische Klinik (Munich, Germany : 1983)|November 15, 1996
[Coronary risk factors in chronic hemodialysis patients]F Lübbecke, F R Matthias, U Richter, et al.
Thrombosis Research|November 15, 1983
Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparinH Ditter, D Heinrich, F R Matthias, et al.
Intensive Care Medicine|August 29, 1998
Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsisB Eisele, M Lamy, L G Thijs, et al.
Pageof 6